• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[缺铁性贫血患者积极治疗和维持治疗期间的2,3-二磷酸甘油酸水平]

[2,3-diphosphoglycerate level during the active and maintenance treatment of iron-deficiency anemia patients].

作者信息

Iordanova E, Dosheva I, Lulcheva F, Tsvetkova N, Dobrev K

出版信息

Vutr Boles. 1985;24(2):78-82.

PMID:4036090
Abstract

The objective of the present study was to obtain information about the duration of tissue hypoxia in patients with iron deficiency anemia. That fact is of importance for the determination of the duration of maintenance iron therapy. The level of 2,3-diphosphoglycerate was studied during the treatment, after the correction of anemic syndrome and after 60-day out-patient department treatment. The data obtained revealed that the level of 2,3-diphosphoglycerate was considerably elevated, as compared with the norm, before the treatment. After the active treatment and correction of anemic syndrome it was decreased, but remaining above the norm. By the 60th day of the out-patient department treatment the decrease continued and the level of 2,3-diphosphoglycerate approached the norm.

摘要

本研究的目的是获取缺铁性贫血患者组织缺氧持续时间的信息。这一事实对于确定维持性铁治疗的持续时间很重要。在治疗期间、贫血综合征纠正后以及门诊治疗60天后,对2,3-二磷酸甘油酸水平进行了研究。获得的数据显示,治疗前2,3-二磷酸甘油酸水平与正常水平相比显著升高。积极治疗和纠正贫血综合征后,其水平下降,但仍高于正常水平。到门诊治疗第60天时,该水平继续下降,2,3-二磷酸甘油酸水平接近正常水平。

相似文献

1
[2,3-diphosphoglycerate level during the active and maintenance treatment of iron-deficiency anemia patients].[缺铁性贫血患者积极治疗和维持治疗期间的2,3-二磷酸甘油酸水平]
Vutr Boles. 1985;24(2):78-82.
2
Ferritin versus ferrous sulphate preparations: a controlled study in sideropaenic patients.
Pharmatherapeutica. 1986;4(10):673-8.
3
[Treatment and prevention of iron deficiency anemia].
Klin Med (Mosk). 1989 Aug;67(8):109-14.
4
Reticulocyte indices rapidly reflect an increase in iron availability for erythropoiesis.网织红细胞指数能迅速反映红细胞生成中铁可利用量的增加。
Haematologica. 2003 Dec;88(12):1422-3.
5
[Tardyferon-depot in the treatment of iron deficiency anemia].[缓释铁在缺铁性贫血治疗中的应用]
Acta Haematol Pol. 1976;7(4):321-5.
6
Treatment of gestational iron deficiency disease with tardyferon; monitoring the effectivity of treatment.
Ther Hung. 1988;36(1):25-8.
7
[The morphofunctional characteristics of the adaptation of the erythron system in patients with iron-deficiency anemia].[缺铁性贫血患者红细胞系统适应性的形态功能特征]
Lik Sprava. 1992 Aug(8):45-8.
8
Iron deficiency anemia and catecholamine metabolism.
Indian Pediatr. 1991 Jan;28(1):51-6.
9
[Treatment of iron deficiency anemia and the prevention of its recurrences using Soviet iron-containing preparations].
Klin Med (Mosk). 1980 Apr;58(4):61-7.
10
Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients.琥珀酸铁蛋白治疗缺铁性贫血:对1000多名患者进行的对照、双盲、多中心临床试验。
Int J Clin Pharmacol Ther Toxicol. 1993 Mar;31(3):103-23.